NASDAQ:LMRI • US5502491062
ChartMill assigns a Buy % Consensus number of 83% to LMRI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-09 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2026-01-05 | Leerink Partners | Initiate | Outperform |
| 2026-01-05 | William Blair | Initiate | Outperform |
| 2026-01-05 | Deutsche Bank | Initiate | Buy |
| 2026-01-05 | Barclays | Initiate | Overweight |
| 2026-01-05 | Wells Fargo | Initiate | Overweight |
| 2026-01-05 | Raymond James | Initiate | Outperform |
| 2026-01-05 | Jefferies | Initiate | Buy |
12 analysts have analysed LMRI and the average price target is 23.05 USD. This implies a price increase of 44.17% is expected in the next year compared to the current price of 15.99.
The consensus rating for LUMEXA IMAGING HOLDINGS INC (LMRI) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering LUMEXA IMAGING HOLDINGS INC (LMRI) is 12.